Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1993 | 1 |
1994 | 1 |
1995 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial.
J Clin Oncol. 1995 Feb;13(2):470-6. doi: 10.1200/JCO.1995.13.2.470.
J Clin Oncol. 1995.
PMID: 7531223
Clinical Trial.
Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.
Loehrer PJ Sr, Kim K, Aisner SC, Livingston R, Einhorn LH, Johnson D, Blum R.
Loehrer PJ Sr, et al.
J Clin Oncol. 1994 Jun;12(6):1164-8. doi: 10.1200/JCO.1994.12.6.1164.
J Clin Oncol. 1994.
PMID: 8201378
Clinical Trial.
The median duration of response was 11.8 months (range, 0.9 to 70.5+), the time to treatment failure 18.4 months (range, 0.8 to 91.9+), and median survival time 37.7 months (range, 2 to 91.9+). CONCLUSION: This trial demonstrates that objective response rates and prolonged …
The median duration of response was 11.8 months (range, 0.9 to 70.5+), the time to treatment failure 18.4 months (range, 0.8 to 91.9+), and …
Item in Clipboard
Knowledge in cancer beliefs: obstacles to care?
Loehrer PJ Sr.
Loehrer PJ Sr.
Cancer Treat Rev. 1993;19 Suppl A:23-7. doi: 10.1016/0305-7372(93)90054-u.
Cancer Treat Rev. 1993.
PMID: 8431929
No abstract available.
Item in Clipboard
Cite
Cite